Propofolectable and hypoperfusion Patient Reports February 10, 2012

Propofolectable Side Effects Report #5782986-6
Propofolectable side effect was reported by a Physician from CHILE on June 10, 2008. Female patient, 43 years of age, was treated with Propofolectable. After drug was administered, patient experienced the following side effects: hypoperfusion, lactic acidosis. Propofolectable dosage: 58 MCG/KG/MIN, 3.5 MG/KG, TWICE, INFUSION; 3.5 MG/KG, INFUSION. During the same period patient was treated with PROPOFOLECTABLE EMULSION, PROPOFOLECTABLE EMULSION, VALPROIC ACID, REMIFENTANYL, LORAZEPAM, MIDAZOLAM, FLUIDS. Patient recovered.